Cheng Luo

19.7k citations
501 papers · 16.2k · 4 hit papers · h-index 59

Impact in

    • Epigenetics and DNA Methylation
    • RNA modifications and cancer
    • Cancer-related gene regulation
    • Sphingolipid Metabolism and Signaling
    • Protein Degradation and Inhibitors
    • Histone Deacetylase Inhibitors Research
    • Cancer-related molecular mechanisms research

Papers in

    • Epigenetics and DNA Methylation 76
    • Cancer-related gene regulation 59
    • Protein Degradation and Inhibitors 55
    • Ubiquitin and proteasome pathways 38
    • RNA modifications and cancer 31
    • Histone Deacetylase Inhibitors Research 26

Cheng Luo

480 papers receiving 15.9k citations

Cheng Luo's Hit Papers

Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1 2023 · 139 citations
1390+5+11Years since publication250500750

Peers

Cheng Luo
Comparison fields: 5 of 186
  • Molecular Biology 10.1k
  • Cancer Research 1.5k
  • Computational Theory and Mathematics 1.1k
  • Oncology 1.6k
  • Cell Biology 917
Replace Ajit Jadhav with:
Ajit Jadhav United States
Manuel C. Peitsch Switzerland
Duxin Sun United States
Robert A. Copeland United States
Md. Imtaiyaz Hassan India
Xiang Chen China
Anton Simeonov United States
John Stephen Lazo United States
Christopher P. Austin United States
Shengyong Yang China
Cheng Luo relative to Ajit Jadhav United States Ajit Jadhav's profile →
Citations per field
00.5×1.6×
Ajit Jadhav · 1×
Citations per year

Countries citing papers authored by Cheng Luo

Since Specialization
Citations

This map shows the geographic impact of Cheng Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Luo more than expected).

Fields of papers citing papers by Cheng Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Luo. The network helps show where Cheng Luo may publish in the future.

Co-authors

The 25 scholars most cited alongside Cheng Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cheng Luo Line = papers co-authored together Cheng Luo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 501 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate
Hit paper breakdown →
2009856
2 2010650
3
Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5
Hit paper breakdown →
2014589
4 2012408
5 2015299
6 2012277
7 2015263
8 2012260
9 2006238
10 2015228
11 2014201
12 2015193
13 2017184
14 2014181
15
YTHDF2 inhibition potentiates radiotherapy antitumor efficacy
Hit paper breakdown →
2023169
16 2012154
17 2021152
18 2014146
19
Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1
Hit paper breakdown →
2023139
20 2017131

About Cheng Luo

Cheng Luo is a scholar working on Molecular Biology, Oncology, Cancer Research, Hematology and Immunology, having authored 501 papers that have together received 16.2k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (76 papers), Cancer-related gene regulation (59 papers), Protein Degradation and Inhibitors (55 papers), Ubiquitin and proteasome pathways (38 papers), RNA modifications and cancer (31 papers), Computational Drug Discovery Methods (27 papers), Histone Deacetylase Inhibitors Research (26 papers) and Multiple Myeloma Research and Treatments (20 papers). The work is most often cited by research in Molecular Biology (10.1k citations), Cancer Research (1.5k citations), Computational Theory and Mathematics (1.1k citations), Oncology (1.6k citations) and Cell Biology (917 citations). Cheng Luo has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Hualiang Jiang, Zhongjie T. Liang, Kaixian Chen, Nitai C. Hait, Sarah Spiegel, Jeremy C. Allegood, Sheldon Milstien, Junyan Lu, Mingyue Zheng and Kuzhuvelil B. Harikumar. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, European Journal of Medicinal Chemistry, PLoS ONE and Bioorganic & Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact